Showing results (151-160 of 447) with videos related to

Sort By:
Pageof 45
Cardio-Oncology (London, England)|September 18, 2020
Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case reportTaku Yasui, Yohei Okuda, Wataru Shioyama, et al.
Cardio-Oncology (London, England)|December 9, 2020
Aerobic and resistance exercise improves Reynolds risk score in overweight or obese breast cancer survivorsKyuwan Lee, Nathalie Sami, Debu Tripathy, et al.
Cardio-Oncology (London, England)|December 9, 2020
Takotsubo syndrome induced by brachytherapy in a patient with endocervical adenocarcinomaAline Cristini Vieira, Mauricio Fernando Silva Almeida Ribeiro, Julianne Lima, et al.
Cardio-Oncology (London, England)|December 9, 2020
In ®Entresto we trustMassimiliano Camilli, Marco Giuseppe Del Buono, Pierantonio Menna, et al.
Cardio-Oncology (London, England)|December 9, 2020
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapyVanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Cardio-Oncology (London, England)|June 17, 2021
Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse modelCory V Noel, Nino Rainusso, Matthew Robertson, et al.
Cardio-Oncology (London, England)|February 3, 2021
A comparative assessment of coronary artery calcification on chest CT scans of patients referred to a cardio-oncology clinicAlison M Brann, Charlotte J Bai, John F Hibbeln, et al.
Cardio-Oncology (London, England)|February 3, 2021
Rationale for setting up a cardio-oncology unit: our experience at Mayo ClinicSergio Barros-Gomes, Joerg Herrmann, Sharon L Mulvagh, et al.
Cardio-Oncology (London, England)|February 3, 2021
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemiaOren Pasvolsky, Avi Leader, Zaza Iakobishvili, et al.
Pageof 45